# A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

> **NCT01260805** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 32 (estimated)

## Conditions studied

- Bioequivalence
- Ethinylestradiol
- Gestodene
- Harmonet

## Interventions

- **DRUG:** Reference Drug
- **DRUG:** Test Drug

## Key facts

- **NCT ID:** NCT01260805
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2011-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01260805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01260805, "A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01260805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*